| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 7.39 MB | Adobe PDF |
Orientador(es)
Resumo(s)
Osteomyelitis treatment is usually described as a challenging issue, mainly because of the necessity of high levels of antimicrobials employed for extended periods, since the infection is characterized by poor blood circulation. Innovative options of targeted and controlled drug delivery systems, presenting sustained antimicrobial release, high concentrations of drugs in the infected areas, low concentrations in the bloodstream, and promotion of osteogenesis, need to be considered.
Descrição
Palavras-chave
Osteomyelitis Antimicrobials Chitosan Nanoparticles
Contexto Educativo
Citação
Falcão J, Zegre M, Bastron S, Ribeiro IA, Gonçalves L, Bettencourt A. Chitosan-based nanoparticles as a dual drug delivery system directed to bone infection therapy. In: 13th iMed.ULisboa Postgraduate Students Meeting, University of Lisbon (Portugal), July 4-5, 2022. Poster 015.